Financials
Income statement
Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
Total reported revenue | — | 72.8B | 71.8B | 66.7B |
Cost of revenue | — | 55.4B | 55.6B | 52.4B |
Gross profit | — | 17.4B | 16.2B | 14.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | -32.3B | 12.9B | 12.4B |
Other operating expenses | — | — | — | — |
Operating income | — | 4.1B | 3.3B | 1.8B |
Non operating interest income | ||||
Income | — | 159M | 104M | 126M |
Expense | — | 111M | 102M | 111M |
Other income expense | — | — | — | — |
Pretax income | — | 2.0B | 3.1B | 2.4B |
Tax provision | — | 772M | 1.1B | 1.5B |
Net income | — | 1.3B | 2.0B | 873M |
Basic EPS | 86.1 | — | — | — |
Diluted EPS | 86.1 | — | — | — |
Basic average shares | 68.4M | — | — | — |
Diluted average shares | 68.4M | — | — | — |
EBITDA | — | 8.6B | 7.3B | 6.3B |
Net income from continuing op. | — | 2.0B | 3.1B | 2.4B |
Minority interests | — | -4M | -3M | -6M |
Preferred stock dividends | — | 0 | 0 | 0 |